The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sesha Sai Nikhil Chintalapati
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astal Laboratories Ltd informed BSE that Sesha Sai Nikhil Chintalapati, belonging to the non-promoter group, was allotted 48,67,348 equity shares on 14 January 2026 under a preferential allotment done through a share swap arrangement. His shareholding in the company jumped sharply from 1.09% (1,17,930 shares) to 11.81% (49,85,278 shares) of total share capital, crossing the 10% threshold under the takeover regulations. Including his person acting in concert (PAC) Venkata Ramchandra Murthy Chintalapati, the combined post-acquisition holding stands at 11.82%. No shares are encumbered, and the acquisition was not through open market but via a share swap, indicating a strategic or promoter-aligned transaction.
The acquirer has crossed the 10% disclosure threshold, which is significant for minority shareholders to monitor. Further acquisitions of 5% or more would trigger an open offer requirement under SEBI takeover norms, so investors should watch for any follow-on disclosures. The share swap route suggests a possible alignment with an existing equity holder rather than fresh capital infusion.